Informed-money record

UTHR · UNITED THERAPEUTICS CORPORATION

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

Bearish filings

500

Named actors

Disclosed $ (bull / bear)

$0 / $580.3M

Recent disclosures

25 of 500+ in the window · linked to source

Date	Who	What	Disclosed $	Receipt
2026-09-03	Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) PAUL MAHON	filed notice to sell	$4.0M	SEC ↗
2026-09-01	Chairperson & CEO ROTHBLATT MARTINE A	sold	$758K	SEC ↗
2026-09-01	Chairperson & CEO ROTHBLATT MARTINE A	sold	$41K	SEC ↗
2026-09-01	Chairperson & CEO ROTHBLATT MARTINE A	sold	$834K	SEC ↗
2026-09-01	Chairperson & CEO ROTHBLATT MARTINE A	sold	$1.8M	SEC ↗

475+ more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →

Dispute or correct this record

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only — a dense name; figures cover the most recent 500. Descriptive, not investment advice. Methodology · Today's notable signals